Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason

More than one in four people with Type 2 diabetes use GLP-1 receptor agonists, a class of widely prescribed medications. However, new research from Stanford Medicine and international collaborators suggests these drugs may be less effective for…

Continue Reading

News Source: www.sciencedaily.com